IFT80
Intraflagellar transport protein 80 homolog
Also known as: FAP167, IFT80_HUMAN, KIAA1374, WDR56
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9P2H3
- Gene
- IFT80
- Ensembl
- ENSG00000068885
- Chromosome
- 3
- Canonical length
- 777 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins
OverviewNCBI Gene
The protein encoded by this gene is part of the intraflagellar transport complex B and is necessary for the function of motile and sensory cilia. Defects in this gene are a cause of asphyxiating thoracic dystrophy 2 (ATD2). Three transcript variants encoding two different isoforms have been found for this gene.[provided by RefSeq, Jun 2010]
Canonical amino-acid sequenceUniProt
777 residues, UniProt reviewed canonical sequence.
>Q9P2H3|IFT80
1 MRLKISLLKE PKHQELVSCV GWTTAEELYS CSDDHQIVKW NLLTSETTQI VKLPDDIYPI
61 DFHWFPKSLG VKKQTQAESF VLTSSDGKFH LISKLGRVEK SVEAHCGAVL AGRWNYEGTA
121 LVTVGEDGQI KIWSKTGMLR STLAQQGTPV YSVAWGPDSE KVLYTAGKQL IIKPLQPNAK
181 VLQWKAHDGI ILKVDWNSVN DLILSAGEDC KYKVWDSYGR PLYNSQPHEH PITSVAWAPD
241 GELFAVGSFH TLRLCDKTGW SYALEKPNTG SIFNIAWSID GTQIAGACGN GHVVFAHVVE
301 QHWEWKNFQV TLTKRRAMQV RNVLNDAVDL LEFRDRVIKA SLNYAHLVVS TSLQCYVFST
361 KNWNTPIIFD LKEGTVSLIL QAERHFLLVD GSSIYLYSYE GRFISSPKFP GMRTDILNAQ
421 TVSLSNDTIA IRDKADEKII FLFEASTGKP LGDGKFLSHK NEILEIALDQ KGLTNDRKIA
481 FIDKNRDLCI TSVKRFGKEE QIIKLGTMVH TLAWNDTCNI LCGLQDTRFI VWYYPNTVYV
541 DRDILPKTLY ERDASEFSKN PHIVSFVGNQ VTIRRADGSL VHISITPYPA ILHEYVSSSK
601 WEDAVRLCRF VKEQTMWACL AAMAVANRDM TTAEIAYAAI GEIDKVQYIN SIKNLPSKES
661 KMAHILLFSG NIQEAEIVLL QAGLVYQAIQ ININLYNWER ALELAVKYKT HVDTVLAYRQ
721 KFLETFGKQE TNKRYLHYAE GLQIDWEKIK AKIEMEITKE REQSSSSQSS KSIGLKPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against IFT80 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.23
- Highest tissue expression
- 26 nTPM
Expression across tissuesHPA
Tissue
- parathyroid gland: 26 nTPM
- pituitary gland: 24 nTPM
- retina: 23 nTPM
- testis: 22 nTPM
- hippocampal formation: 19 nTPM
- spinal cord: 19 nTPM
Single-cell type
- oligodendrocytes: 239 nCPM
- ependymal cells: 214 nCPM
- choroid plexus epithelial cells: 184 nCPM
- bergmann glia: 68 nCPM
- oligodendrocyte progenitor cells: 64 nCPM
- astrocytes: 62 nCPM
Immune cell
- plasmacytoid DC: 1.4 nTPM
- naive CD4 T-cell: 1 nTPM
- T-reg: 1 nTPM
- basophil: 0.9 nTPM
- NK-cell: 0.9 nTPM
- memory B-cell: 0.8 nTPM
Brain region
- white matter: 76 nTPM
- basal ganglia: 48 nTPM
- cerebral cortex: 40 nTPM
- midbrain: 40 nTPM
- choroid plexus: 39 nTPM
- hypothalamus: 37 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about IFT80.
Disease | AllUniProt
Conditions IFT80 is implicated in, by any mechanism.
- Short-rib thoracic dysplasia 2 with or without polydactyly (SRTD2) MIM:611263
Disease | GeneticClinVar
64 pathogenic / likely-pathogenic of 735 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Jeune thoracic dystrophy
- Asphyxiating thoracic dystrophy 2
- Type IV short rib polydactyly syndrome
- Familial cancer of breast
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.99
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.51
- DepMap mean gene effect
- 0.02
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 9% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- apoptotic process
- articular cartilage development
- bone mineralization involved in bone maturation
- canonical NF-kappaB signal transduction
- cartilage homeostasis
- cilium assembly
- endochondral ossification
- establishment or maintenance of cell polarity
- fibroblast growth factor receptor signaling pathway
- gene expression
- growth plate cartilage chondrocyte differentiation
- intraciliary anterograde transport
- keratinocyte proliferation
- limb development
- multicellular organism growth
- negative regulation of keratinocyte proliferation
- negative regulation of non-canonical Wnt signaling pathway
- non-canonical Wnt signaling pathway
- non-motile cilium assembly
- odontoblast differentiation
- osteoblast differentiation
- osteoblast proliferation
- osteoclast differentiation
- phosphatidylinositol 3-kinase/protein kinase B signal transduction
- proteasomal protein catabolic process
- protein stabilization
- protein ubiquitination
- receptor localization to non-motile cilium
- response to inositol
- smoothened signaling pathway
- spinal cord development
- stem cell differentiation
- stem cell proliferation
- tooth eruption
Cellular components
Protein domainsUniProt · Pfam · InterPro
- WD40 repeat
- WD40/YVTN repeat-like-containing domain superfamily
- WD40-repeat-containing domain superfamily
- IFT80/172/WDR35, TPR domain
- WD domain, G-beta repeat
- IFT80/172/WDR35/WDR19 TPR domain
- IFT80, second beta-propeller domain
- IFT80 second beta-propeller
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of IFT80 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads IFT80 as an antibody target. Whether an autoantibody or antibody against IFT80 could matter depends on whether native IFT80 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
IFT80 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label IFT80 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...